Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages 1-6
Publisher
Informa UK Limited
Online
2019-03-28
DOI
10.1080/2162402x.2019.1581531
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities
- (2019) Chamutal Gur et al. OncoImmunology
- Abnormal expression of circulating and tumor-infiltrating carcinoembryonic antigen-related cell adhesion molecule 1 in patients with glioma
- (2018) Jinhu Li et al. Oncology Letters
- CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection
- (2018) Vishal Khairnar et al. Nature Communications
- Expression of CEACAM1 or CEACAM5 in AZ-521 cells restores the type IV secretion deficiency for translocation of CagA by Helicobacter pylori
- (2018) Nicole Tegtmeyer et al. CELLULAR MICROBIOLOGY
- Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21
- (2017) Yongzhi Yang et al. GASTROENTEROLOGY
- Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients
- (2017) Yang Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Analysis ofFusobacteriumpersistence and antibiotic response in colorectal cancer
- (2017) Susan Bullman et al. SCIENCE
- HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2
- (2016) Rachel Yamin et al. Cell Reports
- Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs
- (2016) Anahita Javaheri et al. Nature Microbiology
- Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA
- (2016) Verena Königer et al. Nature Microbiology
- Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis
- (2015) Kosuke Mima et al. GUT
- Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
- (2015) Chamutal Gur et al. IMMUNITY
- Neutrophils Infiltration in the Tongue Squamous Cell Carcinoma and Its Correlation with CEACAM1 Expression on Tumor Cells
- (2014) Ning Wang et al. PLoS One
- Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
- (2013) Aleksandar D. Kostic et al. Cell Host & Microbe
- Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
- (2013) Mara Roxana Rubinstein et al. Cell Host & Microbe
- Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer
- (2012) A Arabzadeh et al. ONCOGENE
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
- (2011) M. Castellarin et al. GENOME RESEARCH
- Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
- (2011) A. D. Kostic et al. GENOME RESEARCH
- The activating receptor NKp46 is essential for the development of type 1 diabetes
- (2009) Chamutal Gur et al. NATURE IMMUNOLOGY
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
- (2009) N. Stanietsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started